Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema-A Swiss Cohort Study

• Autores principales: Ferhat Turgut (Autor), Gábor M. Somfai (Autor), Christoph Tappeiner (Autor), Katja Hatz (Autor), Irmela Mantel (Autor), Aude Ambresin (Autor), Guy Donati (Autor), Viviane Guignard (Autor), Dana Nagyová (Autor), Isabel B. Pfister (Autor), Christine Schild (Autor), Justus G. Garweg (Autor)
• Formato: Libro
• Publicado: MDPI AG, 2024-09-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background/Objectives: Diabetic macular edema (DME) is a significant cause of visual impairment, often treated with anti-vascular endothelial growth factor (anti-VEGF) agents. However, some patients do not respond adequately to this treatment. This study aims to evaluate the contribution of the intr...